cordycepin has been researched along with Candidiasis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abruzzo, G; Allocco, J; Becker, J; Bills, G; Davison, J; Diez, MT; Flattery, A; Gauvin, D; Giacobbe, R; Gill, C; Harris, G; Hsu, MJ; Hu, W; Jiang, B; Kahn, JN; Kauffman, S; Li, Y; Liberator, P; Martel, N; Parish, C; Pelaez, F; Platas, G; Rahkhoodaee, F; Ransom, T; Rodriguez-Suarez, R; Roemer, T; Salowe, S; Sillaots, S; Trosok, S; Veillette, K; Wang, H; Wilson, K; Wiltsie, J; Wisniewski, D; Xu, D; Youngman, P; Zhang, L | 1 |
| McCaffrey, RP; Sugar, AM | 1 |
2 other study(ies) available for cordycepin and Candidiasis
| Article | Year |
|---|---|
PAP inhibitor with in vivo efficacy identified by Candida albicans genetic profiling of natural products.
Topics: Alleles; Amino Acid Sequence; Animals; Antifungal Agents; Aspergillus fumigatus; Biological Products; Candida albicans; Candidiasis; Complex Mixtures; Deoxyadenosines; Drug Evaluation, Preclinical; Drug Resistance, Fungal; Fermentation; Heterozygote; Mice; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Polyadenylation; Polynucleotide Adenylyltransferase; RNA, Messenger; Saccharomyces cerevisiae; Treatment Outcome | 2008 |
Antifungal activity of 3'-deoxyadenosine (cordycepin).
Topics: Adenosine Deaminase Inhibitors; Animals; Antifungal Agents; Candidiasis; Deoxyadenosines; Disease Models, Animal; Drug Interactions; Drug Resistance, Microbial; Enzyme Inhibitors; Male; Mice; Mice, Inbred ICR; Pentostatin; Survival Analysis | 1998 |